RECENT NEWS

Genomics England has completed installation of an enterprise imaging system that will help to support a world-pioneering initiative for cancer research. The programme is linking whole genome sequencing, pathology and radiology data, in what has been described as the world’s largest multimodal cancer research platform.

INTEGRA Biosciences’ pipetting platforms are being used to streamline the liquid handling steps involved in antimicrobial susceptibility testing (AST), contributing to the early detection of antimicrobial resistance (AMR) and helping to direct patients onto the appropriate care pathway as soon as possible.

Mologic, the US subsidiary of Global Access Diagnostics (GADx), has announced that its proprietary COVI-Go SARS-CoV-2 Ag Self-Test received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for over-the-counter home use.

Veterinary diagnostics firm Enalees has announced the opening of a new subsidiary in Germany and the appointment of Philip Hausen as general manager for the Germany-Austria-Switzerland (DACH) region.

The Medical Technologies Directorate at the Department of Health and Social Care (DHSC) is hosting a webinar on Monday 6 March at 11am to promote the recently published Medical Technology Strategy.

Linkam Scientific will present a new cryo-electron microscopy (cryo-EM) research paper at the Microscopy Conference 2023 (MC2023), Darmstadt, Germany: ‘New principle and robot for vitrification of cryo-EM samples with controllable sample thickness and real-time optical inspection’.

Nicolas Shiaelis and Dr Nicole Robb, Oxford University scientists and co-founders of health technology company Pictura Bio, have developed a world-first diagnostic test, powered by artificial intelligence, that can identify known respiratory viruses such as influenza and COVID-19 within five minutes from just one nasal or throat swab.

Health Education England has published a capability framework that will allow for the health and care workforce to build up skills in artificial intelligence and digital healthcare technologies.

Roquefort Therapeutics has signed an exclusive licence and royalty agreement, for the field of medical diagnostics only, with Randox Laboratories, in relation to its Midkine antibody portfolio.

Tens of thousands of patients across the country will benefit from quicker access to tests, with 19 new community diagnostic centres (CDCs) which will perform 1.1 million tests, checks and scans every year set to open later this year.

The laboratory world will meet in Hannover on 9 – 11 May at Labvolution, the European trade fair for laboratory technology and optimised laboratory workflows.

Beckman Coulter Diagnostics and MeMed have announced a strategic partnership to jointly develop and commercialise the proven MeMed BV test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections.

VolitionRx’s Nu.Q vet cancer test is now available for pre-order to veterinarians at the point-of-care through Heska Corporation.

Tasso has announced that the TassoOne Plus, a new high-volume liquid blood collection device, has received CE mark certification and successfully fulfilled all of the performance, safety, and relevant product requirements under the new European Union Medical Device Regulation.

France-based start-up Previa Medical says it has raised €2.1 million in seed funding for SEPSI-SCORE, a specialist AI-based solution designed to improve the early detection of sepsis in healthcare facilities.

Beckman Coulter Life Sciences will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition, focussing on highlighting the benefits of automation to improve laboratory workflows.

IT professionals across health and social care are being invited to have their say over future plans for the IT systems that underpin the NHS.

Terumo Blood and Cell Technologies has announced US Food and Drug Administration (FDA) clearance and official launch of its IMUGARD WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days.

Sophia Genetics is partnering with AstraZeneca to apply its multimodal technology and expertise to the biopharmaceutical company’s oncology portfolio.

Bio-Rad Laboratories has launched StarBright Blue-series and StarBright Yellow-series dyes to provide greater flexibility in conventional and full spectrum flow cytometry applications.